Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor

Hepato-Gastroenterology

Volumn 51, Issue 56, 2004, Pages 413-418

  Lygidakis, N J ^a,b   Singh, Gurusharan ^a   Bardaxoglou, E ^a   Dedemadi, G ^a   Sgourakis, G ^a   Nestoridis, J ^a   Malliotakis, A ^a   Pedonomou, M ^a   Solomou, E K ^a   Safioleas, M ^a   Alamani, Maria ^a   Grigorakos, L ^a   Merikas, E M ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Colorectal tumor; Metastasis; Synchronous liver

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; FOLINIC ACID; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; MITOMYCIN; RECOMBINANT INTERLEUKIN 2;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BOLUS INJECTION; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CHILL; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; EMULSION; FEMALE; FEVER; HEPATIC ARTERY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LEUKOPENIA; LIVER CANCER; LIVER FUNCTION; LIVER HYPERTROPHY; LIVER METASTASIS; LIVER RESECTION; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROWAVE RADIATION; PORTAL VEIN; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME; VEIN LIGATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HEPATECTOMY; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRA-ARTERIAL; IODIZED OIL; LIGATION; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; PORTAL VEIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 11144356676     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lygidakis NJ, Theodorakopoulou M, Dedemadi G, Spentzouris N, Kyriakou A, Pearl A; Resection of unresectable secondary liver tumors-new frontiers in liver surgery. Hepatogastroenterology 1997; 44:1632-1640.
2. Nuzzo G, et al: Resection of hepatic metastases from colorectal cancer. Hepatogastroenterology 1997; 44:199-204.
3. Lygidakis NJ, Stringaris K, Kokinis K, Lyberpoulos K, Raptis S: Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study. Hepatogastroenterology 1996; 43:212-220.
4. Okuno K, et al: Interleukin 12 augments the liver associated immunity and reduces liver metastases. Hepatogastroenterology 1996; 43:11996-1202.
5. Hiei K, et al: Resection of metastatic liver cancer in a patient with an anomalous intrahepatic portal system: A case report. Hepatogastroenterology 1995; 42:1002-1007.
6. Kotanagi H, et al: Blood vessel invasion in metastatic nodes for development of liver metastases in colorectal cancer. Hepatogastroenterology 1996; 43:771-774.
7. Taniguichi H, et al: Comparison of survival between hepatic metastasis of gastric and colorectal cancer. Hepatogastroenterology 1996; 43:897-900.
8. Battista SG, et al: Factors influencing incidence and extension of metachronous liver metastases of colorectal adenocarcinoma: A multivariate analysis. Hepatogastroenterology 1997; 44:1057-1062.
9. Oknna K, et al: Adjuvant hepatic arterial IL 2,MMC and 5-FU after curative resection of colorectal liver metastasis. Hepatogastroenterology 1996; 43:688-691.
10. Ishikawa O: Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer. Hepatogastroenterology 1997; 44:1541-1546.
11. Gazzaniga GM, Ciferri E, Fazio S, Bagarolo C et al: Repeated hepatic resections for recurrent metastasis of colorectal cancer. Hepatogastroenterology 1995; 42:383-386.
12. Lygidakis NJ, Pearl A: Metastatic liver disease - A review. Hepatogastroenterology 1997; 44:1484-1487.
13. Genmari L: Liver metastasis: a many sided therapeutic problem. Hepatogastroenterology 1992; 39:5-9.
14. Lygidakis NJ, Spentzouris N, Dedemadi G: Resectional liver surgery in metastatic liver disease. Hepatogastroenterology 1998; 45:1034-1038.
15. Bhattacharya S, Novel SR, Winslet MS, Hobbs KEF: Iodized oil in the treatment of hepatocellular carcinoma. Br J Surg 1994; 81:1563-1571.
16. Lygidakis NJ, Stringaris K, Kokinis K, Lyberpoulous K, Raptis S: Locoregional chemotherapy versus locoregional combined immunochemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study. Hepatogastroenterology 1996; 43:212-220.
17. Ziren HU, Mueller JM, Zieren S: Resection of colorectal liver metastasis in old patients. Hepatogastroenterology 1994; 41:34-37.
18. Okuno K, Yasutomi M: Locoregional immunochemotherapy in liver carcinoma-present and future. Hepatogastroenterology 1995; 42:578-586.
19. Lygidakis NJ, Ziras N, Parissi J: Resection versus resection combined with adjuvant pre-and postoperative chemoimmunotherapy for metastatic colorectal liver cancer. A new look to an old problem. Hepatogastroenterology 1995; 42:155-161.
20. Lygidakis NJ, Stringaris K: Locoregional chemoimmunotherapy transplenic and transtumoral in vivo immunostimulation. Hepatogastroenterology 1996; 43:440-447.
21. Kemeny M: Regional chemotherapy for liver metastasis from colorectal cancer. Hepatogastroenterology 1992; 39:18-23.
22. Bolton JS, Fuhrman GM: Survival after resection of mutiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231:743-751.
23. Cady B, Stone MD, Mc Dermott Jr WV, et al: Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992; 127:561-568.
24. Kubota K, Makuuchi M, Kusaka K, et al: Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26:1176-1181.
25. Soyer P, Roche A, Elias D, Levesque M: Hepatic metastases from colorectal cancer influnce of hepatic volumetric analysis on surgical decision making. Radiology 1992; 184:695-697.
26. Lygidakis NJ, et al: New frontiers in liver surgery. Two-stage liver surgery for the management of advanced metastatic liver disease. Hepatogastroenterology 1999; 46:2216-2228.
27. Wust, et al: Hyperthermia in combined treatment of cancer. Lancet 2002; 3:Number 9. (Review)
28. Senior K: Hyperthermia and hypoxia for cancer cell destruction. Lancet 2001; Vol 2, No.9: Newsdesk.